BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2013
View Archived Issues
Convergence reports encouraging interim data from phase II study in trigeminal neuralgia
Read More
Regenx Biosciences Consortium receives European Commission grant for rare disease
Read More
A nasal proteasome-based therapy shows promise in animal models of AD
Read More
SUH-1210 simultaneously targets alpha- and beta-secretase activity
Read More
pan-Bcr-Abl inhibitor to overcome mutation-acquired resistance to imatinib identified
Read More
Characterization and in vivo efficacy of novel voltage-gated calcium channel blocker RQ-00311651
Read More
Protalix BioTherapeutics treats first patient in phase I study of PRX-112
Read More
Dainippon Sumitomo gains rights to two Edison Pharmaceuticals compounds
Read More
Long-term results show sapropterin is safe and well tolerated in pediatric patients with PKU
Read More
NIH grant awarded to Actinobac Biomed for Leukothera development
Read More
Biomarin plans phase I/II study of BMN-190 in Batten disease
Read More
Toxicology data encourage clinical development of OMS-721
Read More
Hydrea approved for essential thrombocythemia and polycythemia vera in Japan
Read More
Wakamoto and DWTI sign license agreement for antiglaucoma agent
Read More
Elan closes Tysabri transaction
Read More
Daratumumab granted FDA fast track designation
Read More
Abbott's new test for testicular cancer and birth defects obtains FDA approval
Read More
Mitsubishi Pharma launches BindRin in Germany and Austria
Read More
Cytokinetics begins first-in-human phase I trial of CK-2127107
Read More
Dainippon Sumitomo Pharma's European subsidiary changes name
Read More
Sanofi patents novel K(2P)3.1 blockers
Read More
Theraclone Sciences reports topline data from phase I TCN-202 trial
Read More
Spanish group prepares novel prostanoid EP1 receptor antagonists
Read More
Imperial Innovations researchers describe anti-DDR1 antibodies
Read More
Chiesi Farmaceutici patent describes human neutrophil elastase inhibitors
Read More